129 related articles for article (PubMed ID: 36807188)
1. [Initial Recurrence around the Hilar of the Liver Which Was Difficult to Differentiate from Perihilar Cholangiocarcinoma with Portal Vein Invasion after Resection for Breast Cancer-A Case Report].
Ishii S; Sakata E; Uchida H; Oji M; Nakahara A; Hashidate H; Shibuya H
Gan To Kagaku Ryoho; 2023 Feb; 50(2):251-253. PubMed ID: 36807188
[TBL] [Abstract][Full Text] [Related]
2. [Successful R0 Resection of Hilar Cholangiocarcinoma Invading the Inferior Vena Cava through Left Trisegmentectomy with Combined Resection of the Portal Vein and Inferior Vena Cava after Gemcitabine/Cisplatin Combination Chemotherapy-A Case Report].
Miyajima S; Takeda S; Goda K; Arasawa S; Hoshi T; Hoshi S; Tanaka Y; Takaya H; Fukunaga T; Kajimura K; Inamoto O
Gan To Kagaku Ryoho; 2022 Apr; 49(4):437-439. PubMed ID: 35444129
[TBL] [Abstract][Full Text] [Related]
3. Right hepatectomy for a detoured left hepatic artery in hilar cholangiocarcinoma-report of a rare but rational resection.
Tsai CY; Watanabe N; Ebata T; Mizuno T; Kamei Y; Nagino M
World J Surg Oncol; 2016 Nov; 14(1):288. PubMed ID: 27852277
[TBL] [Abstract][Full Text] [Related]
4. [Long-Term Survival after Surgery with Postoperative Chemotherapy for Perihilar Cholangiocarcinoma with Residual Invasive Carcinoma at Ductal Resection Margins-A Case Report].
Oiwa T; Miura K; Sakata J; Yuza K; Toge K; Hirose Y; Takizawa K; Ichikawa H; Hanyu T; Nakano M; Nagahashi M; Shimada Y; Ishikawa T; Kobayashi T; Wakai T
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1899-1901. PubMed ID: 33468866
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.
Zhu AX; Knox JJ
Oncologist; 2012; 17(12):1504-7. PubMed ID: 23220842
[TBL] [Abstract][Full Text] [Related]
6. A New Strategy of Liver Transplantation for Locally Advanced Unresectable Perihilar Cholangiocarcinoma Using Living Grafts With Simultaneous Resection of Recipients' Hepatic Artery and Portal Vein Without Neoadjuvant Radiation: A Case Report.
Miyagi S; Fujio A; Nakagawa K; Tokodai K; Kashiwadate T; Miyazawa K; Sasaki K; Matsumura M; Nishimaki H; Hibi T; Kamei T; Unno M
Transplant Proc; 2022; 54(6):1643-1647. PubMed ID: 35810018
[TBL] [Abstract][Full Text] [Related]
7. [Successful R0 Resection of Hilar Cholangiocarcinoma by Extrahepatic Bile Duct Resection Due to Accompanying Liver Dysfunction after Neoadjuvant Gemcitabine/Cisplatin/S-1 Combination Chemotherapy-A Case Report].
Higashiguchi M; Yamada D; Akita H; Eguchi H; Iwagami Y; Asaoka T; Noda T; Gotoh K; Kobayashi S; Sakai D; Hatano E; Ioka T; Doki Y; Mori M
Gan To Kagaku Ryoho; 2019 Feb; 46(2):342-344. PubMed ID: 30914554
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
9. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.
Zhang CW; Liu J; Hong DF; Wang ZF; Hu ZM; Huang DS; Shang MJ; Yao WF
Surg Endosc; 2018 Mar; 32(3):1581-1582. PubMed ID: 28779241
[TBL] [Abstract][Full Text] [Related]
10. [Evaluations of total hilar en bloc resection and reconstruction in comparison with portal vein resection and reconstruction in treatment of perihilar cholangiocarcinoma].
Lu CD; Huang J; Wu SD; Fang JZ; Hua YF; Lu CJ; Wang GQ; Shan YY
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):32-39. PubMed ID: 33412631
[No Abstract] [Full Text] [Related]
11. Complete response of recurrent perihilar cholangiocarcinoma following sintilimab combined with lenvatinib plus S-1: a case report and review of literature.
Liu QQ; Yu XH; Tang QB; Chen D; Zhang R; Liu C; Shi XD
Anticancer Drugs; 2024 Jan; 35(1):81-85. PubMed ID: 37227031
[TBL] [Abstract][Full Text] [Related]
12. [Radical surgery for hilar cholangiocarcinoma (Klatskin tumor)].
Ramos Rubio E
Cir Esp; 2007 Jul; 82(1):11-5. PubMed ID: 17580025
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Peritoneal Dissemination of Hilar Cholangiocarcinoma Presenting with Hematuria Six Years after Radical Surgery].
Koizumi N; Nakase Y; Kobayashi H; Takagi T; Fukumoto K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2407-2409. PubMed ID: 28133337
[TBL] [Abstract][Full Text] [Related]
14. Current Management of Perihilar Cholangiocarcinoma and Future Perspectives.
Lewis HL; Rahnemai-Azar AA; Dillhoff M; Schmidt CR; Pawlik TM
Chirurgia (Bucur); 2017; 112(3):193-207. PubMed ID: 28675356
[TBL] [Abstract][Full Text] [Related]
15. Consensus conference on hilar cholangiocarcinoma.
Forsmark CE; Diniz AL; Zhu AX
HPB (Oxford); 2015 Aug; 17(8):666-8. PubMed ID: 26172133
[No Abstract] [Full Text] [Related]
16. [A Case of Liver Metastasis of Intrahepatic Cholangiocarcinoma That Achieved Clinical Complete Response after Gemcitabine and Cisplatin Combination Chemotherapy].
Kim Y; Hata T; Tanizaki K; Okano M; Kawada J; Okuyama M; Yamasaki M; Murakami M; Shimizu J; Miwa H; Imamoto H; Tsujinaka T
Gan To Kagaku Ryoho; 2019 Feb; 46(2):360-362. PubMed ID: 30914560
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors and Patterns of Locoregional Failure After Surgical Resection in Patients With Cholangiocarcinoma Without Adjuvant Radiation Therapy: Optimal Field Design for Adjuvant Radiation Therapy.
Ghiassi-Nejad Z; Tarchi P; Moshier E; Ru M; Tabrizian P; Schwartz M; Buckstein M
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):805-811. PubMed ID: 29063849
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series.
Abdelrahim M; Al-Rawi H; Esmail A; Xu J; Umoru G; Ibnshamsah F; Abudayyeh A; Victor D; Saharia A; McMillan R; Al Najjar E; Bugazia D; Al-Rawi M; Ghobrial RM
Curr Oncol; 2022 May; 29(5):3585-3594. PubMed ID: 35621680
[TBL] [Abstract][Full Text] [Related]
19. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
20. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
